Filing Flows › Comparisons › SVIA vs HSCS
Silvia vs HeartSciences: SVIA and HSCS compared
Silvia is the larger company: $37K of revenue in its latest quarter (Q2 2026) against $2K for HeartSciences (Q1 FY27).
Where the money goes: SVIA and HSCS
Silvia (SVIA) · Q2 2026
Silvia, Q2 2026: revenue $37K, net loss $65.0M, operating cash flow −$11.3M. The chart follows the revenue to costs, profit and cash.
HeartSciences (HSCS) · Q1 FY27
HeartSciences, Q1 FY27: revenue $2K (+10% year over year), net loss $3.2M, operating cash flow −$1.3M. The chart follows the revenue to costs, profit and cash.
| Silvia (SVIA) | HeartSciences (HSCS) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q1 FY27 |
| Revenue | $37K | $2K |
| Revenue growth, Y/Y | — | +10% |
| Operating margin | n/m | n/m |
| Net earnings | −$65.0M | −$3.2M |
| Operating cash flow | −$11.3M | −$1.3M |
Questions
Which is bigger, Silvia or HeartSciences?
Silvia is the larger company: $37K of revenue in its latest quarter (Q2 2026) against $2K for HeartSciences (Q1 FY27).
More: Silvia earnings · how Silvia makes money · HeartSciences earnings · how HeartSciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 13, 2026; 10-Q filed Sep 14, 2026). Fiscal quarters can end on different dates. Not investment advice.